TGF-β, produced by cancer-associated fibroblasts (CAFs) and regulatory T cells (Tregs), suppresses cytotoxic T-cell function and promotes epithelial‒mesenchymal transition (EMT) in breast cancer cells. This evidence concerns the gene TGFB1 and breast cancer.